Utilizes 222nm wavelengths to disrupt the RNA and DNA of pathogens, limiting reproduction
EVO 6" with Care222 provides disinfection* technology without compromising the need for visible light while maintaining visually comfortable lighting
Our EVO 6" with Care222 solutions allow for occupants to be present in the space while pathogen control treatment is occurring because 222nm wavelengths inactivate viruses and bacteria at energy levels that do not penetrate living tissue in skin or beyond the tear layer in eyes
*All references to “disinfection” are referring generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency. Reduction of the pathogenic bioburden is a function of fixture run time and the distance to the UV light source, airflow, room size, shadow areas and/or other factors, and the level of reduction will vary within a specific space. This fixture is not intended for use in the cure, mitigation or prevention of disease and is not certified or approved for use as a medical device by the FDA. It is the obligation of the end-user to consult with a qualified Professional Engineer and a Certified Industrial Hygienist, if applicable, to determine whether this fixture meets the applicable requirements for system performance, code compliance, safety (including safety and hazard alerting signs), suitability and effectiveness for use in a particular application design. In no event will Acuity Brands Lighting be responsible for any loss resulting from any use of this fixture in an application design.
**Refer to product specification sheets at acuitybrands.com/UV-Products for efficacy claims and claim substantiation regarding specific products and pathogens.